SYNGR3
Synaptogyrin-3
Also known as: SNG3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43761
- Gene
- SYNGR3
- Ensembl
- ENSG00000127561
- Chromosome
- 16
- Canonical length
- 229 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Golgi apparatus,Vesicles
OverviewNCBI Gene
This gene encodes an integral membrane protein. The exact function of this protein is unclear, but studies of a similar murine protein suggest that it is a synaptic vesicle protein that also interacts with the dopamine transporter. The gene product belongs to the synaptogyrin gene family. [provided by RefSeq, Dec 2010]
Canonical amino-acid sequenceUniProt
229 residues, UniProt reviewed canonical sequence.
>O43761|SYNGR3
1 MEGASFGAGR AGAALDPVSF ARRPQTLLRV ASWVFSIAVF GPIVNEGYVN TDSGPELRCV
61 FNGNAGACRF GVALGLGAFL ACAAFLLLDV RFQQISSVRD RRRAVLLDLG FSGLWSFLWF
121 VGFCFLTNQW QRTAPGPATT QAGDAARAAI AFSFFSILSW VALTVKALQR FRLGTDMSLF
181 ATEQLSTGAS QAYPGYPVGS GVEGTETYQS PPFTETLDTS PKGYQVPAYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SYNGR3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 125 nTPM
Expression across tissuesHPA
Tissue
- hypothalamus: 125 nTPM
- cerebral cortex: 115 nTPM
- cerebellum: 79 nTPM
- midbrain: 75 nTPM
- amygdala: 64 nTPM
- basal ganglia: 50 nTPM
Single-cell type
- other brain neurons: 64 nCPM
- brain inhibitory neurons: 41 nCPM
- oocytes: 37 nCPM
- brain excitatory neurons: 29 nCPM
- undifferentiated spermatogonia: 13 nCPM
- retinal ganglion cells: 12 nCPM
Immune cell
- naive B-cell: 1.8 nTPM
- NK-cell: 1.8 nTPM
- memory B-cell: 1 nTPM
- memory CD8 T-cell: 0.9 nTPM
- naive CD4 T-cell: 0.7 nTPM
- MAIT T-cell: 0.6 nTPM
Brain region
- pons: 247 nTPM
- thalamus: 242 nTPM
- hypothalamus: 222 nTPM
- cerebral cortex: 193 nTPM
- midbrain: 188 nTPM
- basal ganglia: 158 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.75
- gnomAD pLI
- 0.53
- gnomAD missense Z
- 1.05
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of transporter activity
- regulated exocytosis
- regulation of neurotransmitter uptake
- regulation of synaptic vesicle priming
- substantia nigra development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SYNGR3 as an antibody target. Whether an autoantibody or antibody against SYNGR3 could matter depends on whether native SYNGR3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SYNGR3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SYNGR3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...